Zhaoling Wang, Qi Zheng, Wenjie Xuan, Xisheng Xu, Meiping Lu, Jianqiang Wu, . . . Xuefeng Xu. (2022). Short-term effectiveness of baricitinib in children with refractory and/or severe juvenile dermatomyositis. Frontiers Media S.A..
Chicago Style (17th ed.) CitationZhaoling Wang, Qi Zheng, Wenjie Xuan, Xisheng Xu, Meiping Lu, Jianqiang Wu, Lixia Zou, Yiping Xu, and Xuefeng Xu. Short-term Effectiveness of Baricitinib in Children with Refractory And/or Severe Juvenile Dermatomyositis. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationZhaoling Wang, et al. Short-term Effectiveness of Baricitinib in Children with Refractory And/or Severe Juvenile Dermatomyositis. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.